ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.370
+0.130 (5.80%)
At close: Aug 13, 2025, 4:00 PM
2.360
-0.010 (-0.42%)
After-hours: Aug 13, 2025, 7:58 PM EDT
Oncternal Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Cash & Equivalents | 84.94 | 99.12 | 60.65 | 490.25 | 20.56 | 4.58 | Upgrade |
Short-Term Investments | 209.79 | 259.17 | 302.3 | - | - | - | Upgrade |
Cash & Short-Term Investments | 294.73 | 358.29 | 362.95 | 490.25 | 20.56 | 4.58 | Upgrade |
Cash Growth | -31.70% | -1.28% | -25.97% | 2284.73% | 349.06% | -69.93% | Upgrade |
Other Receivables | 1.78 | 2.45 | 1.38 | - | - | - | Upgrade |
Receivables | 1.78 | 2.45 | 1.38 | - | - | - | Upgrade |
Prepaid Expenses | 8.02 | 15.7 | 9.81 | 13.08 | 6.69 | 0.96 | Upgrade |
Other Current Assets | 19.91 | 19.45 | 0.01 | 1.38 | 0.03 | 0.05 | Upgrade |
Total Current Assets | 324.44 | 395.88 | 374.15 | 504.72 | 27.27 | 5.59 | Upgrade |
Property, Plant & Equipment | 47.69 | 45.19 | 46.41 | 13.06 | 12.6 | 10.47 | Upgrade |
Other Intangible Assets | - | - | - | 0.21 | 0.43 | 0.64 | Upgrade |
Total Assets | 372.13 | 441.07 | 420.55 | 518 | 40.3 | 16.7 | Upgrade |
Accounts Payable | 2.44 | 3.63 | 5.1 | 3.04 | 2.83 | 0.78 | Upgrade |
Accrued Expenses | 24.92 | 30.77 | 16.97 | 7.34 | 9.21 | 2.79 | Upgrade |
Current Portion of Leases | 0.9 | 0.77 | 0.8 | 0.49 | 0.27 | 0.23 | Upgrade |
Current Income Taxes Payable | - | 0.68 | 1.47 | - | - | - | Upgrade |
Other Current Liabilities | - | 0.37 | 0.69 | - | - | 1.71 | Upgrade |
Total Current Liabilities | 28.26 | 36.22 | 25.04 | 10.87 | 12.31 | 5.5 | Upgrade |
Long-Term Leases | 3.52 | 2.47 | 3.61 | 1.91 | 1.07 | 1.33 | Upgrade |
Other Long-Term Liabilities | 0.9 | 0.75 | 0.57 | 0.28 | - | - | Upgrade |
Total Liabilities | 32.68 | 39.44 | 29.22 | 13.06 | 13.38 | 6.84 | Upgrade |
Common Stock | 0.03 | 0.03 | 0.02 | 0.02 | 188.43 | 116.23 | Upgrade |
Additional Paid-In Capital | 231.58 | 205.74 | 36.11 | 7.48 | - | - | Upgrade |
Retained Earnings | -1,234 | -1,201 | -1,140 | -1,104 | -161.51 | -106.36 | Upgrade |
Comprehensive Income & Other | 0.03 | 0.13 | 0.13 | - | - | - | Upgrade |
Total Common Equity | -1,003 | -994.95 | -1,103 | -1,097 | 26.92 | 9.86 | Upgrade |
Minority Interest | 1,342 | 1,397 | 1,495 | 1,602 | - | - | Upgrade |
Shareholders' Equity | 339.45 | 401.64 | 391.34 | 504.94 | 26.92 | 9.86 | Upgrade |
Total Liabilities & Equity | 372.13 | 441.07 | 420.55 | 518 | 40.3 | 16.7 | Upgrade |
Total Debt | 4.42 | 3.24 | 4.41 | 2.4 | 1.33 | 1.56 | Upgrade |
Net Cash (Debt) | 290.31 | 355.06 | 358.54 | 487.85 | 19.22 | 3.02 | Upgrade |
Net Cash Growth | -31.67% | -0.97% | -26.51% | 2437.73% | 536.77% | -78.61% | Upgrade |
Net Cash Per Share | 2.26 | 3.63 | 5.81 | 7.93 | 0.13 | 0.03 | Upgrade |
Filing Date Shares Outstanding | 133.42 | 129.54 | 61.62 | 61.54 | 194.27 | 122.77 | Upgrade |
Total Common Shares Outstanding | 133.42 | 128.05 | 59.88 | 61.54 | 194.27 | 122.77 | Upgrade |
Working Capital | 296.18 | 359.67 | 349.11 | 493.85 | 14.96 | 0.08 | Upgrade |
Book Value Per Share | -7.51 | -7.77 | -18.43 | -17.82 | 0.14 | 0.08 | Upgrade |
Tangible Book Value | -1,003 | -994.95 | -1,103 | -1,097 | 26.49 | 9.22 | Upgrade |
Tangible Book Value Per Share | -7.51 | -7.77 | -18.43 | -17.82 | 0.14 | 0.08 | Upgrade |
Land | - | 1.41 | 3.07 | - | - | - | Upgrade |
Buildings | - | 21.1 | 22.49 | - | - | - | Upgrade |
Machinery | - | 6.49 | 4.54 | 3.27 | 2.75 | 2.14 | Upgrade |
Construction In Progress | - | 2.45 | 8.74 | 1.61 | 0.35 | 7.85 | Upgrade |
Leasehold Improvements | - | 21.82 | 10.95 | 10.54 | 10.52 | 0.08 | Upgrade |
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.